NIHR Latest Funding Opportunities

The following new funding opportunities are available from NIHR:

Health Services and Delivery Research Programme
18/73 Health Services and Delivery Research Programme researcher-led (standard)
18/74 Health Services and Delivery Research Programme researcher-led (evidence synthesis)
18/75 HS&DR Mental Health Themed Call

Health Technology Assessment Programme
18/65 Health Technology Assessment Programme researcher-led (evidence synthesis)

18/66 Health Technology Assessment Programme researcher-led (primary research)
18/67 HTA Mental Health Themed Call (evidence synthesis)
18/68 HTA Mental Health Themed Call (primary research)

Invention for Innovation Programme
Product Development Awards – Call 16

Public Health Research Programme
18/69 Benefits of the provision of health and wellbeing education during Initial Teaching Training and Continual Professional Development of qualified teachers
18/70 Fire and rescue visits to improve health outcomes
18/71 Sex and relationship interventions for young people with learning disabilities
18/72 Gang violence and gang related harms to health



Latest Funding Opportunities from NIHR

Efficacy and Mechanism Evaluation Programme
An NIHR and MRC partnership
18/62 EME Mental Health Themed Call – round 2
18/58 EME Researcher Led – new brain tumour highlight notice added

Public Health Research Programme
18/61 PHR Mental Health Themed Call – round 2
18/60 Researcher-led – new brain tumour highlight notice added

Research for Patient Benefit Programme
Competition 36 – including Mental Health Themed Call round 2

For more information and a list of all current funding opportunities, please visit the NIHR website.


Latest call from NIHR

Latest calls from NIHR

Clinician Scientist Award
Round 18

Efficacy and Mechanism Evaluation Programme
An NIHR and MRC partnership
18/55 Improving Safety and Efficacy Through Targeted Drug Delivery
18/56 Neurodegenerative Disorders
18/57 Type 2 Diabetes
18/58 EME Researcher Led
18/59 Mechanisms of action of health interventions

Health Technology Assessment Programme

18/24 Early reoperation for patients with residual glioblastoma
18/25 Microstructural scaffold insertion following microfracture for chondral knee defects
18/26 Surgical management of pressure ulcers
18/27 Alternative bisphosphonate regimens for the prevention of osteoporotic fracture in adults
18/28 Paediatric wrist fracture
18/29 Preventing job loss in people with long term physical health conditions
18/30 Hysteroscopic removal of retained placenta
18/31 Discontinuation of growth hormone treatment in pubertal children
18/32 Management of orthostatic hypotension
18/33 Valuing the benefits and harms of antenatal and new born screening programmes in the UK
18/34 Routinely used interventions for improving attachment in infants and young children
18/35 Behavioural intervention to treat anxiety in adults with autism and  moderate to severe learning disabilities
18/36 Anticonvulsant augmentation of antipsychotic medication in the management of psychosis
18/37 Repair of digital nerve injury
18/38 Selective serotonin reuptake inhibitor for the treatment of anxiety in adults with autism
18/39 Earlier active management of ovarian hyperstimulation syndrome
18/40 Short-term use of benzodiazepines for the acute management of acute low back pain
18/41 Clinical and cost effectiveness of alternative urinary catheter design
18/42 Cystic fibrosis
18/43 Rotation of the fetal head at full cervical dilatation
18/44 Pre-hospital pain management
18/45 Proton pump inhibitor therapy for refractory gastro-oesophageal reflux symptoms
18/46 Pharmacological management of post-traumatic seizures  
18/47 Outpatient cervical ripening for induction of labour
18/48 Radiotherapy in first-line treatment of diffuse large B-cell lymphoma
18/49 Radiofrequency denervation for low back pain
18/50 Frail older people in primary care
18/51 Extended duration haemodialysis
18/52 Management of isolated or incidental subsegmental pulmonary embolism
18/53 Clozapine for children and young people with treatment resistant schizophrenia

Integrated Clinical Academic Programme for non-medical healthcare professionals
An NIHR and Health Education England partnership
Round 4

Public Health Research Programme
18/60 Researcher-led (including complex health and care needs in older people and London Devolution Deal highlight notices)

For more information and a list of all current funding opportunities, please visit the NIHR website.


NIHR – Latest Funding Opportunities

Here are the latest funding opportunities from NIHR:

Health Technology Assessment Programme
18/14 Anti-reflux therapy in idiopathic pulmonary fibrosis
18/15 Non-surgical vs surgical management of unstable ankle fractures
18/16 Nebulised saline in patients with COPD
18/17 Antenatal computerised cardiotocography
18/18 Active case finding of coeliac disease
18/19 The cost effectiveness of venous thromboembolism risk assessment tools for hospital inpatients
18/20 Bronchodilators and corticosteroids in bronchiectasis
18/21 Strategies for testing and treating TB infection
18/22 Foot orthoses for children with symptomatic flat feet
18/23 Calcium supplementation for women at high-risk of pre-eclampsia

Public Health Research Programme
Public Health Review Team


Latest Events from NHS and NIHR

Latest Events from NHS and NIHR

NIHR i4i Mental Health Challenge Awards reopen
Following a successful 2017 competition, the NIHR i4i Mental Health Challenge Awards will re-launch on 1 Feb at the 2018 MQ Mental Health Science Meeting. Find out more about the event and the Challenge.

NHS Digital Innovation Workshop
As part of the Research Advisory Group, NHS Digital is hosting an Innovation Workshop on Thursday 25 January 2018. Read more


Information Day Notes – NIHR Public Health Research Programme

Here are some notes from an Information Day hosted by Research Design Service North East in December 2017 on the NIHR Public Health Research Programme.

Research Design Service Information Day – NIHR Public Health Research Programme

Andrew Cook – Consultant Advisor

NIHR consists of the following:

  • Faculty – to develop people through fellowships and training awards
  • Infrastructure, including the Clinical Research Network, Research Design Service and Clinical Research Facilities
  • Programmes, including PHR, RfPB, EME, HD&SR, i4i etc

The Public Health Research Programme covers non NHS (ie not doctors or disease course. There is no cap on the funding (other than the overall PHR budget), and they are not wedded to any particular methods.

There does need to be a health or wellbeing outcome, so having a healthy lifestyle is necessary, training with a URBNFit Amazon ball and having a good nutrition.

PHR does not cover intervention costs, these will need to come from local authorities or from charities or from in kind contributions. PHR will not fund the development of a new intervention. they will however fund the adaptation of bringing an intervention to the UK, eg adapting a US intervention into UK standards/procedures. Intervention costs could be funded RfPB or PGfAR.

PHR are looking for projects that change practice. The key users should be evidence users, for example charities, public health workers.

There is an expectation that there will be a multi-disciplinary team which includes:

  • Delivery
  • Statistician
  • Qualitative specialist
  • Public

Money for NIHR programmes is top sliced from the health service budgets so the outcome needs to demonstrate an impact on society and improve health, reducing health inequalities. PHR are interested in projects which change policy rather than impact individual behaviour. They are open to joint funding projects with charities where the charity pays the intervention cost for example. They like projects which inform local decisions eg policy, urban regeneration, bus pass travel, turning off street lights vs crime, road accidents…

There are 2 funding streams, commissioned research (with the next round closing in March) and Researcher-led, apply at any time with panel dates per year.

PHR will fund pilot studies.

You need to check out what has been funded before and say what your project can do to add to this work.


Eileen Kaner – Institute for Health & Society, Newcastle University

Eileen also sits on the NICE Board which draws on evidence from NIHR projects.

You can take a look at the NICE Guidelines to identify the gaps in literature.

PHR looks at funding projects which improve publis health at a non=-NHS level (health & wellbeing improvement within 5 years).projects need to be relevant and important to policy makers, practitioners and people.

It is a two stage process and following the outline proposal you will receive feedback. Once the proposal has passed the first submission stage it then goes to Board where it is given a DBM (Designated Board Member) who will introduce the project. A further two DBMs are assigned to the project. Once introduced, the Board will vote anonymously and the proposal receives an average score. Board members are looking for research excellence as well as real world relevance.

Bear in mind that it can take 12 months or more before funding is agreed and you reach the contracting stage.

Inequalities are key in PHR, especially modifiable differences between groups of people eg. Income, socio-economic position, location etc. They want to move away from looking at individuals to population level, looking at groups of people where you can have the most benefit.

PHS will fund quasi and natural experiements.

Some tips:

  • If you are doing a pilot study you will neeed to have clear stop/go criteria and think about how you could broaden out the study.
  • Justify your sample size.
  • Evidence value for money.
  • Need a logical model or theory of change.
  • Clearly describe how the project can lead to change.
  • What will this mean in terms of impact per cost.
  • Respond to the Board comments fully.

If the Board like the proposal they will work with the team to develop a sundable proposal if it is important and of relevance.

Bear in mind that these are contracts for delivery, they are not grants. As such NIHR will monitor what you are doing and will expect regular reports. If things change throughout the lifetime of the project, Research design Service can advise the best course. You will have to go back to the admin team at Public Health to find a solution.


Raghu Lingham –  Institute for Health & Society, Newcastle University

Go back to the call and look at the PICOS Framework:

  • Population
  • Intervention
  • Comparitor group (eg what is the usual care)
  • Outcome
  • Study design

Then look at your research question and flesh out the PICOS framework.

One person can’t know everything so you need a multi-disciplinary team.

PPI is really important. Public Health research is about research in the real world so you need to engage with the public about their views (see INVOLVE guidance). How can the public change your ideas and how can their opinion inform your protocol?

It can be useful to get letters of support from Local Authorities for example. They can also be used to support intervention costs (which are not covered by the Programme). Ask them what they are already doing and what can the project do to tweak this. The project can’t pay for the intervention  but it could pay for training costs for people who are delivering interventions by giving them a new set of skills for example.

You are able to work in more than one geographical area and can use the FUSE network to disseminate or to find partners. (Can also use the School for Primary Care).

Try to conceptualise the whole study in a diacgram, to see how each of the parts fit together.


Luke Vale – Associate Director, Research Design Service North East

Some final points:

RDS can provide advice on methodology, quant vs qual, statistics, cost effectiveness, links with CTUs.

Proposals need to clearly state what it is that they want to achieve and what the best way of achieving this will be. Is it plausible? Look at a logiv model.

The public need to be involved in defining the research topic. They need to be involved and embedded throughout the research. Be sure that you ask for funding for your PPI as part of your project. Also, RDS has small amounts of money available to fund travel for PPI.

Where the project has commercial partners you will need to be really careful about IP and what happens to the results.

RDS manage a PPI Panel which meets two times per month. There are sixteen members of the public involved in a round table discussion and you can pitch your ideas to them.

There is also a Young Persons Advisory Group (YPAG) where you can access young people who have been trained in research and ethics where you can pitch your project and have it challenged.



















Latest Opportunities from NIHR

Here are the latest research funding opportunities from NIHR

Efficacy and Mechanism Evaluation Programme
An NIHR and MRC partnership

17/142 Osteoporosis
17/143 Inherited myopathies and muscular dystrophies
17/144 Mechanisms of action of behavioural and psychological interventions to improve health
17/145 Efficacy and Mechanism Evaluation Programme researcher-led
17/146 Mechanisms of action of health interventions

Health Technology Assessment Programme

17/115 The role of prophylactic antibiotics for botulinum toxin A injections for overactive bladder
17/116 Letrozole for improving fertility in women with polycystic ovary syndrome
17/117 Therapeutic interventions for self-harm in adolescents – an individual patient data meta-analysis
17/118 The effectiveness of early treatment with amitriptyline for the prevention of post-herpetic neuralgia
17/119 Non-invasive neurally adjusted ventilator assist for neonates requiring respiratory support
17/120 Hyperosmolar therapy in traumatic brain injury
17/121 Gastrointestinal side effects in cancer immune checkpoint therapy
17/122 Joint distraction for knee osteoarthritis without alignment correction
17/123 Intensive day patient versus inpatient treatment for anorexia nervosa in adult specialised eating disorder services
17/124 Psychosocial intervention for internalised stigma to improve outcomes for people with schizophrenia
17/125 Eye movement desensitisation and reprocessing for symptoms of post-traumatic stress disorder in adults with learning disabilities
17/126 Selective serotonin reuptake inhibitor to prevent depression following traumatic brain injury
17/127 Partial removal of dentinal caries in permanent teeth
17/128 Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of COPD
17/129 Exercise therapy for people with pulmonary hypertension
17/130 Pre-pregnancy weight loss for women on long acting reversible contraception (LARC)
17/132 Intervention or expectant management for early onset fetal growth restriction in twin pregnancy
17/133 Scanning laser ophthalmoscopy for diabetic eye screening
17/134 Identification of older patients likely to require enhanced care on discharge from hospital
17/135 Cytoreductive surgery with hyperthermic intraoperative peritoneal chemotherapy
17/136 Sepsis
17/137 Dose of oxytocin during induction of labour
17/138 Surgery for early osteoarthritis
17/139 Reducing the risk of anxiety disorders in children of parents seeking help for their own anxiety
17/140 Optimising the use of statin therapy in cardiovascular disease prevention

Public Health Research Programme

17/149 Public Health Research Programme researcher-led
17/151 Public Health Research Programme evidence synthesis